Royal DSM announced that Mr. Rob Routs will retire as Chairman and member of the DSM Supervisory Board at the close of the Annual General Meeting of Shareholders to be held on 6 May 2021. The Supervisory Board has appointed Mr. Thomas Leysen to succeed him as Chairman. Furthermore it announces that the Supervisory Board will nominate Mrs. Corien M. Wortmann-Kool to join as a new Supervisory Board member. Mr. Rob Routs has been a member of the DSM Supervisory Board since April 2010 and Chairman since May 2011. He was reappointed for a final term by the 2020 Annual General Meeting of Shareholders to facilitate a smooth transfer and continuity to the new Co-CEO leadership structure. When Mr. Rob Routs took over, DSM had successfully transformed from a chemical company into a Life Sciences and Materials Sciences company. Mr. Thomas Leysen (1960, Belgian national) has joined the Supervisory Board in 2020 and will succeed Mr. Rob Routs after the upcoming Annual General Meeting of Shareholders.